Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines (Q39273399)

10 September 2017

title

Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines (English)

1 reference

10 September 2017

0 references

neoplastic stem cells

1 reference

inferred from title

head and neck neoplasms

1 reference

Andreas E Albers

8

0 references

author name string

Tian Liao

1

1 reference

10 September 2017

Andreas M Kaufmann

2

1 reference

10 September 2017

Xu Qian

3

1 reference

10 September 2017

Voramon Sangvatanakul

4

1 reference

10 September 2017

Chao Chen

5

1 reference

10 September 2017

Tina Kube

6

1 reference

10 September 2017

Guoyou Zhang

7

1 reference

10 September 2017

publication date

23 September 2012

1 reference

Journal of Cancer Research and Clinical Oncology

10 September 2017

published in

1 reference

10 September 2017

volume

139

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

159-170

1 reference

Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

NK cells recognize and kill human glioblastoma cells with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

A flow cytometry-based assay to assess minute frequencies of CD8+ T cells by their cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Removing all obstacles: a critical role for p53 in promoting tissue renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Molecular genetics of human aldehyde dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1311-2

Lack of B7.1 and B7.2 on head and neck cancer cells and possible significance for gene therapy

21 January 2018

1 reference

12 December 2020

Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity

1 reference

12 December 2020

MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer

1 reference

12 December 2020

Evidences of cervical cancer stem cells derived from established cell lines

1 reference

12 December 2020

Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells

1 reference

12 December 2020

T cell-tumor interaction directs the development of immunotherapies in head and neck cancer

1 reference

12 December 2020

10.1007/S00432-012-1311-2

Identifiers

DOI

1 reference

10 September 2017

1 reference